


346 F.3d 1094
United States Court of Appeals,
Federal Circuit.
GENZYME CORPORATION and Mount Sinai School of Medicine of New York University, Plaintiffs-Appellants,
v.
TRANSKARYOTIC THERAPIES, INC., Defendant-Appellee.
No. 02-1312.
|
Oct. 9, 2003.
|
Rehearing and Rehearing En Banc Denied Jan. 21, 2004.
Synopsis
Owner of patent for method of producing human enzyme sued competitor for infringement. The United States District Court for the District of Delaware, 2001 WL 1530375, Gregory M. Sleet, J., granted summary judgment of noninfringement, and appeal was taken. The Court of Appeals, Rader, Circuit Judge, held that patent, calling for insertion of exogenous genes encoding enzyme of interest into host cell's chromosomal material, was not infringed by accused process, which called for insertion of promoters which activated endogenous genes encoding enzyme of interest.
 
Affirmed.
 
Linn, Circuit Judge, concurred in part and dissenting in part and filed a separate opinion.
 
